<DOC>
	<DOCNO>NCT02000388</DOCNO>
	<brief_summary>To evaluate efficacy , tolerability safety intranasal ketorolac tromethamine ( SPRIX ) option pain management post vasectomy patient .</brief_summary>
	<brief_title>Intranasal Ketorolac Tromethamine ( SPRIX ) Short Term Pain Management Post-Vasectomy Pain</brief_title>
	<detailed_description />
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>INCLUSION CRITERIA 1 . Male Subject must age twenty five ( 25 ) year sixty four ( 64 ) 2 . Willing able provide inform consent 3 . Has make decision undergo vasectomy 4 . Subject good general physical condition assess Principal Investigator EXCLUSION CRITERIA 1 . Current treatment know allergy sensitivity form ketorolac tromethamine , aspirin , non steroidal anti inflammatory drug ( NSAIDs ) Ethylenediaminetetraacetic acid ( EDTA ) 2 . Use narcotics/opiate medical marijuana within one ( 1 ) week prior baseline visit entire study participation 3 . Use illegal drug self report 4 . History drug alcohol abuse within five ( 5 ) year screen visit 5 . History suicide attempt within five ( 5 ) year screen visit 6 . A diagnosis severe neuropsychiatric disease 7 . Subject currently receive investigational drug ( ) participate clinical trial involve investigational drug ( ) within thirty ( 30 ) day screen visit 8 . Subject history follow coronary condition : ( chronic stable angina currently treat long act nitrate , chronic stable angina require treatment short act nitrate 90 day visit 1 , angina occur sexual intercourse last six month , unstable angina within six month visit 1 9 . Resting , sit blood pressure ( BP ) &gt; 160mm Hg systolic pressure &gt; 100mm Hg diastolic pressure screening . If patient find untreated significant hypertension screen antihypertensive treatment initiate , assessment study eligibility defer BP antihypertensive medication stable least one month . For patient previously diagnose hypertension , antihypertensive medication must stable least one month prior screen . 10 . Known suspected cerebrovascular bleeding , hemorrhagic diathesis incomplete hemostasis , high risk bleeding , history bleed problem low platelet count coagulation disorder therapy affect homeostasis 11 . Active peptic ulcer disease , recent GI bleeding perforation , history peptic ulcer GI bleed 12 . History asthma , urticaria allergictype reaction take aspirin non steroidal inflammatory drug ( NASIDs ) 13 . Subject sixty four ( 64 ) year age 14 . Subject clinically significant renal function liver abnormality 15 . Subject history swell face , mouth , tongue , lip , gum , neck , throat ( angioedema ) cardiac decompensation similar condition 16 . Major surgery schedule within 3 week screen entire participation study 17 . Current exfoliative dermatitis , StevensJohnson syndrome toxic epidermal necrolysis 18 . Any condition opinion investigator make subject unsuitable study</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>